Israel Englander Revolution Medicines, Inc. Call Options Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$30.14 - $40.68 $2.78 Million - $3.76 Million	-92,400 Reduced 71.08%	37,600 $1.46 Million
Q1 2024 May 15, 2024	BUY	$26.56 - $33.55 $2.89 Million - $3.65 Million	108,800 Added 513.21%	130,000 $4.19 Million
Q4 2023 Feb 14, 2024	SELL	$18.35 - $34.12 $1.15 Million - $2.14 Million	-62,800 Reduced 74.76%	21,200 $608,000
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $1.7 Million - $2.27 Million	84,000 New	84,000 $2.25 Million
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $618,800 - $893,550	35,000 Added 58.04%	95,300 $2.27 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $1.05 Million - $1.57 Million	60,300 New	60,300 $1.19 Million

241

161M

251K

133K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $5.21B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.